BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/27/2014 5:15:00 PM | Browse: 902 | Download: 829
 |
Received |
|
2013-10-29 16:29 |
 |
Peer-Review Started |
|
2013-10-30 19:39 |
 |
To Make the First Decision |
|
2013-11-21 18:57 |
 |
Return for Revision |
|
2013-11-22 10:39 |
 |
Revised |
|
2013-12-31 03:59 |
 |
Second Decision |
|
2014-01-20 18:55 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-01-20 19:28 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2014-03-10 21:48 |
 |
Typeset the Manuscript |
|
2014-04-25 19:05 |
 |
Publish the Manuscript Online |
|
2014-05-18 12:31 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Topic Highlights |
Article Title |
Antitubercular therapy in patients with cirrhosis: Challenges and options
|
Manuscript Source |
Invited Manuscript |
All Author List |
Naveen Kumar, Chandan Kumar Kedarisetty, Sachin Kumar, Vikas Khillan and Shiv Kumar Sarin |
Funding Agency and Grant Number |
|
Corresponding Author |
Dr. Shiv Kumar Sarin, MD, DM, DSc, FNA, Professor and Head, Department of Hepatology, Institute of Liver and Biliary Sciences, Vasant Kunj, Plot No.D-1, New Delhi 110070, India. shivsarin@gmail.com |
Key Words |
Antitubercular therapy; Drug hepatotoxicity; Multidrug-resistant tuberculosis; Immune dysfunction |
Core Tip |
Treatment of tuberculosis (TB) in patients with underlying cirrhosis is a challenge because of the compromised liver functions and high risk of hepatotoxicity. There is no consensus regarding the treatment and monitoring of TB in this group of patients. This paper reviews the differences in diagnosis, treatment, monitoring, hepatotoxicity and other issues in treatment of TB in patients with cirrhosis. Suggestions for treatment of TB in patients with different grades of cirrhosis, as well as monitoring guidelines, are provided. Finally, issues such as liver transplantation, multidrug-resistant TB and reactivation of TB by interferon are briefly reviewed. |
Publish Date |
2014-05-18 12:31 |
Citation |
Kumar N, Kedarisetty CK, Kumar S, Khillan V, Sarin SK. Anti-tubercular therapy in patients with cirrhosis: Challenges and options. World J Gastroenterol 2014; 20(19): 5760-5772 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i19/5760.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i19.5760 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345